logo
Doctors not against mandatory price display, object to use under Act 723

Doctors not against mandatory price display, object to use under Act 723

The Sun04-05-2025
PETALING JAYA: Doctors are not against price transparency for medicines but object to the enforcement of the recent mandatory price labelling move under the Price Control and Anti-Profiteering Act 2011 (Act 723), the Malaysian Medical Association (MMA) said in a statement today.
Ahead of the planned march from the Health Ministry to the Prime Minister's Office (PMO) on Tuesday, titled 'Doctors Betrayed: The Long Walk to Putrajaya, MMA's Private Practitioners Section (PPS) chairman Datuk Dr Parmjit Singh Kuldip Singh said the symbolic walk aims to express the medical fraternity's deep disappointment over the application of Act 723 — a law not originally intended for the medical profession.
The march would highlight concerns about the various unanswered questions on the medicine price display and the unresolved issue of stagnant private general practitioner consultation fees, a longstanding issue since 1992.
'We wish to reiterate that doctors are not against price transparency but strongly oppose Act 723 being used in the medical profession,' he said in a statement.
Dr Parmjit said the march would go ahead as planned if there are no objections, as MMA have submitted all necessary documents to inform the relevant authorities about the gathering.
He said a memorandum will be handed over to the PMO through a joint effort between the association and other doctors' associations during the march.
Last week, Health Minister Datuk Seri Dr Dzulkefly Ahmad and Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali announced that the mandatory price labelling would take effect on May 1.
In a joint statement, they said the move aims to ensure the public can make informed choices by knowing, comparing, and selecting the best prices when managing their medication expenses.
'This initiative is being introduced in line with the Madani Government's commitment to promoting price transparency through the Medicine Price Transparency Mechanism (MKHU).
'It will be enforced under the Price Control and Anti-Profiteering (Price Marking for Medicines) Order 2025, pursuant to the Price Control and Anti-Profiteering Act 2011 (Act 723),' they said.
The price labelling requirement applies to all medicines for human use, including prescription and non-prescription drugs, over-the-counter (OTC) medicines, traditional remedies, health supplements, and extemporaneous preparations.
It covers all private healthcare facilities and community pharmacies regulated under the Private Healthcare Facilities and Services Act 1998 [Act 586] that sell, supply, or administer medicines.
Following this, MMA called for the suspension of the policy's rollout to ensure that the association's concerns were adequately discussed and resolved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Compliance of drug price display rule at 55%, Dewan Rakyat told
Compliance of drug price display rule at 55%, Dewan Rakyat told

The Star

time2 days ago

  • The Star

Compliance of drug price display rule at 55%, Dewan Rakyat told

KUALA LUMPUR: Checks during the first three months of enforcing drug price transparency showed that 55% of 1,639 private healthcare facilities nationwide complied satisfactorily, says Deputy Health Minister Lukanisman Awang Sauni. The remaining 45% had incomplete or inaccessible price displays, he added. ALSO READ: Drug price display order gazetted, to come into effect May 1 "These findings indicate the need for continued monitoring, guidance sessions and phased enforcement for non-compliant premises," he said during Minister's Question Time in the Dewan Rakyat on Tuesday (Aug 12). To ensure greater transparency and fairness in private healthcare pharmacy services, Lukanisman said the Health Ministry plans to conduct a comprehensive evaluation from September. "This aims to assess the impact of the drug pricing policy and guide improvements in the system. "It will inform (these) improvements to ensure transparency and fairness in private healthcare pharmacy services," he added. ALSO READ: Medicine price display rule to proceed on Aug 1, says Health Minister The display of drug prices, which came into effect on May 1 under the Price Control and Anti-Profiteering (Marking of Prices for Drugs) Order 2025, is part of the government's efforts to enhance public access to drug price information. This initiative seeks to ensure competitive pricing and informed consumer choices. From Aug 1, the ministry began inspections and monitoring, issuing warnings for non-compliance, with full enforcement and fines scheduled to commence on Jan 1. The phased approach aims to give private healthcare providers, including clinics, hospitals and community pharmacies, time to adjust and comply with the new regulations. The initiative faced some resistance from non-governmental organisations and medical associations, particularly concerning the regulation of consultation fees, which have not been reviewed for 30 years. ALSO READ: Medicine price display rule to stay However, Lukanisman noted that the ministry remains committed to inclusive engagement with stakeholders, including the Malaysian Medical Association, to address these issues and ensure a balanced approach to healthcare regulation. Addressing concerns raised by Jimmy Puah Wee Tse (PH-Tebrau) about rising medical costs, Lukanisman highlighted the ministry's ongoing efforts to implement interim Diagnosis-Related Group (DRG) systems in private facilities by 2027. "The DRG data will guide private facilities in setting reasonable prices, although it won't regulate profit margins," he said. DRG systems classify hospital cases with similar clinical characteristics and resource usage, allowing for a standardised payment system based on the diagnosis and treatment provided.

RM90mil Madani grant helps nearly 39,000 SMEs go digital
RM90mil Madani grant helps nearly 39,000 SMEs go digital

New Straits Times

time3 days ago

  • New Straits Times

RM90mil Madani grant helps nearly 39,000 SMEs go digital

JOHOR BARU: Some 38,804 small and medium enterprises (SMEs) nationwide embraced digitalisation last year under the Geran Digital PMKS Madani (GDPM) scheme, with approved funding worth RM89.6 million. Deputy Communications Minister Teo Nie Ching said 2,838 recipients were private clinics and pharmacies, marking about 19 per cent of the sector operating in premises across the country, based on Malaysian Medical Association data. "This shows the effectiveness of the GDPM in helping SMEs digitise services. This year, we are focusing on the health sector, targeting at least 50 per cent of private clinics and pharmacies," she said after launching the Johor leg of GDPM Fest 2025 in Permas Jaya today. The government has approved an additional RM50 million for the programme this year, with RM30 million channelled to the Malaysian Communications and Multimedia Commission (MCMC) via telecommunications companies to strengthen SME digital adoption, particularly in healthcare. The Geran Digital PMKS Madani, or the Madani Micro, Small and Medium Enterprises Digital Grant, is a government initiative to help SMEs digitise their businesses. The grant offers matching funds of up to 50 per cent, or a maximum of RM5,000, for eligible businesses to subscribe to digital services. Its aim is to enhance SME efficiency and competitiveness through the use of digital technology. The effort reflects the government's continued commitment to implementing digitalisation initiatives, a core pillar of the 13th Malaysia Plan (13MP). Teo said digital health records would allow patients to access services across clinics without repeating paperwork, complementing but not replacing MySejahtera.

Nearly 39,000 SMEs adopt digitalisation through GDPM scheme
Nearly 39,000 SMEs adopt digitalisation through GDPM scheme

New Straits Times

time4 days ago

  • New Straits Times

Nearly 39,000 SMEs adopt digitalisation through GDPM scheme

JOHOR BARU: Some 38,804 small and medium enterprises (SMEs) embraced digitalisation last year under the Geran Digital PMKS Madani (GDPM) scheme, with approved funding worth RM89.6 million. Deputy Communications Minister Teo Nie Ching said 2,838 recipients were private clinics and pharmacies, representing about 19 per cent of the sector's operations, based on Malaysian Medical Association data. "This shows the effectiveness of the GDPM in helping SMEs digitalise their services. "This year, we are focusing on the health sector, targeting at least 50 per cent of private clinics and pharmacies," she said after launching the Johor leg of the GDPM Fest 2025 in Permas Jaya here yesterday. The government has approved an additional RM50 million for the programme this year, with RM30 million channelled to the Malaysian Communications and Multimedia Commission via telecommunications companies to strengthen SME digital adoption, particularly in healthcare. The GDPM, or the Madani Micro, Small and Medium Enterprises Digital Grant, is a government initiative to help SMEs digitalise their businesses. The grant offers matching funds of up to 50 per cent, or a maximum of RM5,000, to eligible businesses to subscribe to digital services. It aims to enhance SME efficiency and competitiveness through the use of digital technology. The effort reflects the government's continued commitment to implementing digitalisation initiatives, a core pillar of the 13th Malaysia Plan. Teo said digital health records would allow patients to access services across clinics without repeating paperwork, complementing but not replacing the MySejahtera application.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store